GHK-Cu is being discussed as a potential treatment for male patternbaldness. Users are sharing experiences and asking about its effectiveness and side effects.
A 28-year-old male experiencing early male patternbaldness is considering using Pyrilutamide (KX-826) as an alternative to finasteride due to side effects. He seeks to maintain his current hair without regrowth and is concerned about potential side effects like reduced libido.
A 21-year-old male diagnosed with telogen effluvium and male patternbaldness started taking finasteride, which initially slowed hair shedding and slightly thickened hair. The doctor recommended iron and vitamin D supplements, and the user is considering minoxidil but wants to stabilize shedding first.
A 21-year-old male diagnosed with telogen effluvium and male patternbaldness started oral finasteride, which initially slowed hair loss and slightly thickened hair, but experienced increased shedding after surgery. The doctor recommended iron and vitamin D supplements, and the user is seeking additional advice.
A 29-year-old male is using Minoxidil 5%, Finasteride 1mg, rosemary oil, and keto shampoo daily to combat male patternbaldness. He recently noticed baby hairs and stopped hairline recession, feeling optimistic about future progress.
Scientists at UCLA have developed a promising treatment for male patternbaldness using a molecule called PP405, which can potentially stimulate dormant hair follicles. Initial trials showed significant results within a week, but larger clinical trials are needed to confirm its efficacy and safety.
The conversation discusses managing seborrheic dermatitis (sebderm) and male patternbaldness (MPB) with treatments like finasteride, coal tar shampoo, Nizoral, and oral minoxidil. Users suggest dietary changes, regular shampooing, and using antifungal products to control sebderm before considering minoxidil.
A 26-year-old male started minoxidil treatment for male-patternbaldness and saw significant regrowth in three months. He is considering finasteride but is hesitant due to potential side effects.
A dermatologist recommended PRP (Platelet Rich Plasma) and GFC (Growth Factor Concentrate) for patternbaldness, but online sources suggest they may not be effective. The user is seeking opinions on these treatments.
Testosterone within the normal range does not significantly contribute to male patternbaldness (MPB); DHT is the main factor that can be controlled. Genetics play a crucial role in hair loss, and treatments like finasteride and dutasteride, which block DHT, can help despite potentially raising testosterone levels.
The conversation discusses the pros and cons of dutasteride for male patternbaldness, with a focus on its long half-life. The user, a physician, also mentions that switching from finasteride to dutasteride can cause temporary hair loss until dutasteride reaches effective levels or accelerates the hair cycle.
Dutasteride is likely the most effective treatment for male patternbaldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.
A 30-year-old female with PCOS and male patternbaldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.
Creatine might speed up hair loss in those prone to male patternbaldness, possibly due to increased DHT levels. Some users experience no issues when using creatine with treatments like finasteride, minoxidil, or dutasteride.
Creatine may accelerate hair loss in those genetically prone to male patternbaldness, but stopping its use can lead to hair regrowth. Treatments discussed include minoxidil, finasteride, tretinoin, derma rolling, and herbal remedies like saw palmetto.
Creatine may increase hair loss in those with male patternbaldness (MPB) due to increased DHT, but whey protein generally does not affect hair loss. Finasteride and minoxidil are used to manage hair loss, and some users report increased shedding with creatine but not with whey protein.
The conversation discusses natural methods for addressing male patternbaldness, with the original poster using a plant-based diet, herbs, scalp massages, pumpkin seed oil, and dermapen treatments, while avoiding pharmaceuticals like minoxidil and finasteride due to concerns about side effects. Other users suggest that pharmaceuticals like finasteride may be necessary for significant hair loss, but the original poster remains committed to natural approaches.
Scalp pain alongside hair loss may indicate inflammation rather than just male patternbaldness. Treatments mentioned include triamcinolone acetonide, fluocinonide, Head & Shoulders shampoo, aloe vera gel, finasteride, and 2% Nizoral.
A 20-year-old male experienced early hair thinning due to male patternbaldness and successfully thickened his hair using oral finasteride and topical minoxidil. The conversation highlights the importance of early action and overcoming fear of medication side effects.
Filtered shower heads may improve scalp and hair health but do not affect male patternbaldness (MPB). Genetics and factors like DHT and scalp tension are more significant in hair loss.
The user experienced hair thinning and was diagnosed with alopecia incognito and male patternbaldness. They are using minoxidil, finasteride, and dutasteride scalp injections, reporting gradual improvement with no side effects.
PP405, a potential treatment for male patternbaldness, shows promise with some participants experiencing hair regrowth in early trials. However, it is not yet considered a cure and may be used alongside existing treatments like minoxidil and finasteride.
Caffeine may slightly improve hair thickness if you don't have male patternbaldness. Its effectiveness is questioned, and clinical approval is uncertain.
The user experienced hair loss diagnosed as chronic Telogen Effluvium and male patternbaldness, treated with finasteride and minoxidil, later switching to dutasteride due to side effects but with limited success. The user plans to return to finasteride due to side effects from dutasteride, while others suggest maintaining consistent treatment and considering additional options like oral minoxidil and lifestyle changes.
The conversation discusses the potential effects of spearmint on acne and male patternbaldness (MPB). Concerns are raised about spearmint's androgen-suppressing effects and its suitability for men.
A 26-year-old man shared his positive results after 10 months of treating male patternbaldness using a regimen that includes Estradiol Enanthate, DHPA, Bicalutamide, Dutasteride, oral and topical Minoxidil, and a dermaroller. He experienced mild gynecomastia and reduced body hair as side effects but was satisfied with the outcome.
KX-826 is undergoing Phase III trials in China as a potential treatment for male patternbaldness, with some users considering it as an alternative or addition to finasteride and dutasteride. Opinions on its effectiveness vary, with some users reporting positive results and others finding it expensive and ineffective.
The conversation is about concerns over creatine potentially worsening hair loss in individuals with male patternbaldness (MPB) while using finasteride. Some users suggest avoiding creatine if prone to MPB, while others note no definitive link between creatine and hair loss.
The conversation discusses severe hair loss, possibly due to telogen effluvium or male patternbaldness, lasting over three years. Suggested treatments include minoxidil, finasteride, and dermarolling, with a recommendation to consult a dermatologist.
PP405 may encourage earlier hair growth and slightly increase visible hair count but does not reverse hair follicle miniaturization in male patternbaldness. It does not address damage to the dermal papilla or broken Wnt signaling.